Leprosy

Throughout the ages leprosy has been one of the most dreaded diseases and its victims the most shunned. Almost all cultures have believed that persons who contracted leprosy were spiritually unclean. In modern times the disease has still retained some of its mythical character, and many people do not realize that leprosy is a disease that is only mildly contagious and not fatal. In the early 1990s the World Health Organization estimated that about 5.5 million people had leprosy.

Cause and symptoms.

Leprosy is caused by a rod-shaped bacterium, Mycobacterium leprae, a relative of the tuberculosis bacillus. The organism was identified in 1874 by Armauer Hansen, a Norwegian physician, and an alternative name for leprosy is Hansen's disease. The infection is very slow to develop, ranging from six months to ten years, and children are much more susceptible than adults.

There are two main types of reaction to M. leprae in the body. In the milder form of the disease, tuberculoid leprosy, the body's cells crowd around the invading organisms in the deep skin layers, which are the first areas of infection. This response sometimes seals off the infection from the rest of the body or at least limits its spread. The reaction, however, destroys hair follicles, sweat glands, and nerve endings at the site of infection. The skin above the site becomes dry and discolored and loses its sense of touch. Fingers and toes that have no feeling are easily injured, and, if the patient has not been trained to take protective measures, they may in time become mutilated and fall off.

In the second and more contagious form of the disease, lepromatous leprosy, the body is not able to mount a resistance, and the M. leprae multiply freely in the skin. Large, soft bumps, or nodules, appear over the body and face. Mucous membranes of the eyes, nose, and throat may be invaded. In extreme cases the voice may change drastically, blindness may occur, or the nose may be destroyed.
Treatment and Research.

Until sulfa drugs were developed in the 1940s and were found to be helpful, there was no satisfactory treatment. Patients were merely isolated in an attempt to protect the larger community, and many victims hid. To avoid the undesirable side effects of sulfa drugs, a group of related drugs known as sulfones was developed. Many patients improve with these drugs, especially those with the tuberculoid form of the disease. In most cases treatment must continue for years. Research was long hampered by scientists' inability to induce leprosy in animals in order to study the disease. In 1960 it was found that M. leprae could be grown on the footpads of mice, but the yield was low. A search then began for an animal with a body temperature similar to that of the mouse footpad and the cooler parts of the human body on which the bacteria thrive. In 1971 it was discovered that leprosy could be established in the nine-banded armadillo and other animals. In 1976 it was found that armadillos get leprosy in the wild.